Boehringer Ingelheim
Generated by Meeveem AI
"A family owned pharmaceutical company advancing health for people and animals since 1885."
Ingelheim am Rhein
•1000+ Employees
•Pharmaceuticals
About Boehringer Ingelheim
Boehringer Ingelheim develops breakthrough medicines and vaccines for both human and animal health. The company focuses on areas with high unmet medical needs, including oncology, respiratory diseases, metabolic conditions, and infectious diseases across species. With deep expertise in research and development, the company brings scientific innovations from discovery through to global delivery. Founded in 1885 and still family owned, Boehringer Ingelheim operates across more than 130 markets with 54,300 colleagues worldwide. The business invests heavily in long-term research, dedicating over 22% of revenue to R&D. This independence allows the company to prioritise patient and animal outcomes over short term pressures.
Illustrative visual - may not reflect the actual offering.
Illustrative visual - may not reflect the actual offering.
54300
Team Members
1885
Founded
Bootstrap
Funding
Hybrid
Work Environment
Our Vision
A world where people and animals everywhere live longer, healthier lives supported by breakthrough medical science and sustained access to care.
Our Mission
At Boehringer Ingelheim, our mission is to improve the health of people and animals everywhere in the world through innovative medicines and vaccines.